Apr 032023
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Joenja | leniolisib | 3/24/2023 | To treat activated phosphoinositide 3-kinase delta syndrome | Drug Trials Snapshots | |
| Rezzayo | rezafungin | 3/22/2023 | To treat candidemia and invasive candidiasis | ||
| Zynyz | retifanlimab-dlwr | 3/22/2023 | To treat metastatic or recurrent locally advanced Merkel cell carcinoma | Drug Trials Snapshot | |
| Daybue | trofinetide | 3/10/2023 | To treat Rett syndrome | Drug Trials Snapshot | |
| Zavzpret | zavegepant | 3/9/2023 | To treat migraine |
Sorry, the comment form is closed at this time.